Synthetic Cell SpudCell Sparks Debate in Biotechnology

On July 2, researchers at the University of Minnesota unveiled SpudCell, a lab-created system capable of consuming, growing, and dividing—marking a pivotal moment in bioengineering. The preprint, posted on bioRxiv, has ignited debate before peer review, with scientists split on its implications.

A Lab-Created System with 36 Enzymes

The system, developed by Kate Adamala and colleagues, comprises 36 purified enzymes, a fatty membrane, and a minimal genome 50 times smaller than a typical bacterial cell. Adamala, a synthetic biologist at the university, emphasized SpudCell is not “alive” but a “framework for generating chemicals.”

Unlike natural cells, SpudCell relies on externally supplied fats, sugars, and enzymes, lacking the ability to produce its own energy or ribosomes. Yet the team claims it can produce proteins and replicate, albeit in a controlled lab setting.

Funding Questions and Peer Review Doubts

The study’s release coincided with the launch of Adamala’s nonprofit, Biotic, prompting scrutiny over potential conflicts of interest. “I don’t take offense to the criticism,” she said, stressing her focus on climate solutions.

Potential Applications in Medicine and Industry

Adamala envisions SpudCell as a platform for creating medicines, fertilizers, and plastics without petroleum.

The system could also function as a portable lab, dried and reactivated on demand.

A Cautionary Leap in Synthetic Biology

SpudCell builds on earlier work, such as the J. Craig Venter Institute’s 2016 “minimal cell” project. Its “bottom-up” approach, achieving a full cell cycle in a petri dish, is unique. Still, Adamala acknowledged the technology is “decades from replacing petrochemicals.”

As the field evolves, researchers stress the need for peer review. Rinaldi noted, “The hype may fade, but the science could evolve.” For now, SpudCell stands as both a breakthrough and a reminder of the delicate balance between innovation, funding, and public perception.